MARKET PULSE-Sarepta, AstraZeneca, Pinnacle, Tarena, AMD

Mon Apr 21, 2014 2:02pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

April 21 (Reuters) - U.S. stocks rose slightly on Monday as investors found few reasons to push indexes sharply higher following a strong rally last week and ahead of key earnings releases. The Dow Jones industrial average was up 0.23 percent at 16,446.81, the S&P 500 was up 0.31 percent at 1,870.71 and the Nasdaq Composite was up 0.51 percent at 4,116.438.

** HALLIBURTON CO, $62.77, +3.07 pct

The world's No. 2 oilfield services company, reported better-than-expected quarterly results, helped by robust drilling activity in Russia, Saudi Arabia and Angola.

** SAREPTA THERAPEUTICS INC, $35.4304, +45.21 pct

** PROSENSA HOLDING NV, $5.2999, +4.53 pct

Sarepta said it would start new trials to revive the chance of approval for its experimental muscle disorder drug after the U.S. Food and Drug Administration advised the company to submit new safety and efficacy data.   Continued...